Central neurokinin 3 receptors increase systemic oxytocin release: Interaction with norepinephrine

Experimental Neurology

Volumn 184, Issue 2, 2003, Pages 1027-1033

  Bealer, Steven L ^a   Flynn, Francis W ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF WYOMING   (United States)

Author keywords

Microdialysis; Noradrenergic receptors; Paraventricular nucleus; Senktide; Tachykinin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; NEUROKININ 3 RECEPTOR; NORADRENALIN; OXYTOCIN; PHENTOLAMINE; SENKTIDE; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BRAIN FUNCTION; BRAIN VENTRICLE; CANNULATION; CONTROLLED STUDY; DIALYSATE; ENDOCRINE FUNCTION; FEMALE; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMPLANT; MICRODIALYSIS; NONHUMAN; OXYTOCIN BLOOD LEVEL; OXYTOCIN RELEASE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING; THALAMUS MIDLINE NUCLEUS;

EID: 0842342522     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2003.08.012     Document Type: Article

References (48)

1. Armstrong W.E. Hypothalamic supraoptic and paraventricular nuclei. Paxinos G. The Rat Nervous System. Forebrain and Midbrain. vol. 1:1985;119-128 Academic Press, New York.
2. Bealer S.L. Histamine releases norepinephrine in the paraventricular nucleus/anterior hypothalamus of the conscious rat. J. Pharmacol. Exp. Ther. 264:1993;734-738.
3. Bealer S.L., Crowley W.R. Noradrenergic control of central oxytocin release during lactation in rats. Am. J. Physiol. 274:1998;E453-E458.
4. Bealer S.L., Crowley W.R. Neurotransmitter interaction in release of intranuclear oxytocin in magnocellular nuclei of the hypothalamus. Ann. N.Y. Acad. Sci. 897:1999;182-191.
5. Bealer S.L., Crowley W.R. Stimulation of central and systemic oxytocin release by histamine in the paraventricular hypothalamic nucleus: evidence for an interaction with norepinephrine. Endocrinology. 140:1999;1158-1164.
6. Bealer S.L., Crowley W.R. Histaminergic control of oxytocin release in the paraventricular nucleus during lactation in rats. Exp. Neurol. 171:2001;317-322.
7. Bealer S.L., Crowley W.R. Angiotensin II-induced release of oxytocin: interaction with norepinephrine and role in lactation. Regul. Pept. 111:2003;41-46.
8. Bert L., Rodier D., Bougault I., Allouard N., Le-Fur G., Soubrie P., Steinberg R. Permissive role of neurokinin NK(3) receptors in NK(1) receptor mediated activation of the locus coeruleus revealed by SR 142801. Synapse. 43:2002;62-69.
9. Carpentier C., Baude A. Immunocytochemical localisation of NK3 receptors in the dorsal vagal complex of rat. Brain Res. 734:1996;327-331.
10. Chen L.W., Guan Z.L., Ding Y.Q. Neurokinin B receptor (NK3)-positive neurons expressing c-fos after chemical noxious stimulation of the peritoneum: a double staining study in the nucleus tractus solitarius of the rat. J. Hirnforsch. 38:1997;363-367.
11. Crowley W.R., Armstrong W.E. Neurochemical regulation of oxytocin secretion in lactation. Endocr. Rev. 13:1992;33-65.
12. Crowley W.R., Shyr S.-W., Kacsoh B., Grosvenor C.E. Evidence for stimulatory noradrenergic and inhibitory dopaminergic regulation of oxytocin release in the lactating rat. Endocrinology. 121:1987;14-20.
13. Cunningham E.T. Jr., Sawchenko P.E. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J. Comp. Neurol. 274:1988;60-76.
14. Dam T.V., Escher E., Quirion R. Visualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktide. Brain Res. 506:1990;175-179.
15. Day T.A., Ferguson A.V., Renaud L.P. Facilitatory influence of noradrenergic afferents in the excitability of rat paraventricular nucleus neurosecretory cells. J. Physiol. 355:1984;237-249.
16. De Laurentiis A., Pisera D., Duvilanski B., Rettori V., Lasaga M., Seilicovich A. Neurokinin A inhibits oxytocin and GABA release from the posterior pituitary by stimulating nitric oxide synthase. Brain Res. Bull. 53:2000;325-330.
17. Ding Y.Q., Shigemoto R., Takada M., Ohishi H., Nakanishi S., Mizuno N. Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat. J. Comp. Neurol. 364:1996;290-310.
18. Ding Y.Q.R., Shi J., Su L.U., Xu J.Q., Su C.J., Guo X.E., Gong J. Intracerebroventricular injection of senktide-induced Fos expression in vasopressin containing hypothalamic neurons in the rat. Brain Res. 882:2000;95-102.
19. Eguchi T., Takano Y., Hatae T., Saito R., Nakayama Y., Shingeyoshi Y., Okamura H., Krause J.E., Kamiya H. Antidiuretic action of tachykinin NK-3 receptor in the rat paraventricular nucleus. Brain Res. 743:1996;49-55.
20. Flynn F.W. Brain tachykinins in electrolyte and cardiovascular homeostasis. Peptides. 111:2003;158.
21. Flynn F.W. Central injections of tachykinin NK3 receptor agonist activates oxytocinergic neurons in the accessory magnocellular neurosecretory system. Regul. Pept. 110:2003;171.
22. Hattori T., Morris M., Alexander N., Sundberg D.K. Extracellular oxytocin in the paraventricular nucleus: hyperosmotic stimulation by in vivo microdialysis. Brain Res. 506:1990;169-171.
23. Hattori T., Sundberg D.K., Morris M. Central and systemic oxytocin release: a study of the paraventricular nucleus by in vivo microdialysis. Brain Res. Bull. 28:1992;257-263.
24. Helke C.J., Krause J.E., Mantyh P.W., Couture R., Bannon M.J. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors and regulatory mechanisms. FASEB J. 4:1990;1606-1615.
25. Jung M., Michaud J.C., Steinberg R., Barnouin M.C., Hayar A., Mons G., Souilhac J., Emonds-Aut X., Soubrie P., Le Fur G. Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin NK3 receptor stimulation. Neuroscience. 74:1996;403-414.
26. Kapoor J.R., Sladek C.D. Substance P and NPY differentially potentiate ATP and adrenergic stimulated vasopressin and oxytocin release. Am. J. Physiol. 280:2001;R69-R78.
27. Lang R.E., Heil J.W.E., Aanten D., Hermann K., Unger T., Rascher W. Oxytocin unlike vasopressin is a stress hormone in the rat. Neuroendocrinology. 37:1983;314-316.
28. Langlois X., Wintmolders C., te Riele P., Leysen J.E., Jurzak M. Detailed distribution of neurokinin 3 receptors in the rat, guinea pig, and gerbil brain: a comparative autoradiographic study. Neuropharmacology. 40:2001;242-253.
29. Lincoln D.W., Paisley A.C. Neuroendocrine control of milk ejection. J. Reprod. Fertil. 65:1982;571-586.
30. Ludwig M. Dendritic release of vasopressin and oxytocin. J. Neuroendocrinol. 10:1998;881-895.
31. Maggi C.A. The mammalian tachykinin receptors. Gen. Pharmacol. 26:1995;911-944.
32. Marco N., Thirion A., Mons G., Bougault I., Le Fur G., Sobrie P., Steinberg R. Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig. Neuropeptides. 32:1998;481-488.
33. Massi M., Saija A., Polidori C., Perfumi M., Gentili L., Costa G., DeCaro G. The hypothalamic paraventricular nucleus is a site of action for the central effect of tachykinins on plasma vasopressin. Brain Res. Bull. 26:1991;149-154.
34. Nagashima A., Takano Y., Tateishi K., Matsuoka Y., Hamaoka T., Kamiya H. Central pressor actions of neurokinin B: increases in neurokinin B contents in discrete nuclei in spontaneously hypertensive rats. Brain Res. 499:1989;198-203.
35. Neumann I., Landgraf R., Takahashi Y., Pittman Q.J., Russell J.A. Stimulation of oxytocin release within the supraoptic nucleus and into blood by CCK-8. Am. J. Physiol. 267:1994;R1626-R1631.
36. Nishioka T., Anselmo-Franci J.A., Li P., Callahan M.F., Morris M. Stress increases oxytocin release within the hypothalamic paraventricular nucleus. Brain Res. 781:1998;57-61.
37. Parker S.L., Crowley W.R. Central stimulation of oxytocin release in the lactating rat: interaction of neuropeptide Y with alpha-1-adrenergic mechanisms. Endocrinology. 132:1993;658-666.
38. Raby W., Renaud L.P. Dorsomedial medulla stimulation activates rat supraoptic oxytocin and vasopressin neurons through different pathways. J. Physiol. 417:1989;279-294.
39. Saigo A., Takano Y., Matsumoto T., Tran M., Yakayama Y., Saito Y., Yamada K., Kamiya H. Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats. Neurosci. Lett. 159:1993;187-190.
40. Sawchenko P.E., Swanson L.W. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res. Rev. 4:1982;275-325.
41. Scholtz J.C., Hoffman G.E., Stricker E.M., Sved A.F. Decreases in arterial pressure activate oxytocin neurons in conscious rats. Am. J. Physiol. 273:1997;R1474-R1483.
42. Smith M.E., Flynn F.W. Distribution of Fos-like immunoreactivity within the rat brain following intraventricular injection of the selective NK3 receptor agonist senktide. J. Comp. Neurol. 2000;426.
43. Steinberg R., Rodier D., Souiclhac J., Bougault I., Emonds-Alt X., Soubrie P., Le Fur G. Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: an in vivo microdialysis study. J. Neurochem. 65:1995;2543-2548.
44. Stoessl A.J., Hill D.R. Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [H3]senktide. Brain Res. 534:1990;1-7.
45. Stricker E.M., Verbalis J.G. Interaction of osmotic and volume stimuli in regulation of neurohypophyseal secretion in rats. Am. J. Physiol. 250:1986;R267-R275.
46. Takano Y., Nagashima A., Hagio T., Tateishi K., Kamiya H. Role of central tachykinin peptides in cardiovascular regulation in rats. Brain Res. 528:1990;231-237.
47. Takano Y., Nakayama Y., Matsumoto T., Saito R., Kamiya H. The mechanism of central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the hypothalamus in rats. Regul. Pept. 46:1993;360-363.
48. Wotjak C.T., Landfraf R., Ganster J., Kohl G., Holsboer F., Engelmann M. Release of vasopressin and oxytocin within the rat hypothalamus and into blood in response to repeated swim stress: new insights into the regulatory capacity of peptidergic neurons. Neuroscience. 85:1998;1209-1222.